Ecolab Inc.

Ecolab Inc.

0IFA.L
Ecolab Inc.GB flagLondon Stock Exchange
286.52
USD
+4.12
- -
81.07BMarket Cap
Ecolab Inc.
0IFA.L
(London Stock Exchange)

Recent

price

286.52

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Ecolab Inc. Ecolab Inc. provides water treatment, hygiene, sanitation, and infection prevention solutions and services to commercial, industrial, and institutional customers worldwide. The company offers comprehensive science-based products and services including cleaning and sanitizing chemicals, water management systems, energy optimization technologies, pest elimination solutions, and digital insights platforms; it serves sectors such as food and beverage processing, healthcare, hospitality, life sciences, high-tech including semiconductors and data centers, oil and gas, and industrial manufacturing. Founded in 1923 as Economics Laboratory and headquartered in Saint Paul, Minnesota, Ecolab employs approximately 48,000 associates and operates in more than 170 countries, delivering personalized on-site service to advance food safety, maintain clean environments, and promote sustainability. In August 2025, the company agreed to acquire Ovivo's electronics ultra-pure water business for $1.8 billion to strengthen its high-tech water offerings for semiconductor and AI manufacturing, with the deal expected to close in the first quarter of 2026; it previously divested its global surgical solutions business including the Microtek product line to Medline in August 2024.